SPP1 and in situ carcinoma: A study examining the stepwise predictive value of 18 biomarkers including cNfL and cOPN and MRI lesion load concluded that baseline cNfL combined with OPN and CLL2 correctly predicted the clinical activity status of 91% of the individuals with CIS or MS.